Publications 2021

Valestrand L, Berntsen NL, Zheng F, Schrumpf E, Hansen SH, Karlsen TH, Blumberg RS, Hov JR, Jiang X, Melum E (2021)
Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells
Clin. Exp. Immunol., 203 (2), 304-314
DOI 10.1111/cei.13541

Publications 2018

Alberts R, de Vries EMG, Goode EC, Jiang XJ, Sampaziotis F, Rombouts K, Bottcher K, Folseraas T, Weismuller TJ, Mason AL, Wang WW, Alexander G, Alvaro D, Bergquist A, Bjorkstrom NK, Beuers U, Bjornsson E, Boberg KM, Bowlus CL, Bragazzi MC, Carbone M, Chazouilleres O, Cheung A, Dalekos G, Eaton J et al. (2018)
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis
Gut, 67 (8), 1517-1524
DOI 10.1136/gutjnl-2016-313598

Berntsen NL, Fosby B, Tan C, Reims HM, Ogaard J, Jiang X, Schrumpf E, Valestrand L, Karlsen TH, Line PD, Blumberg RS, Melum E (2018)
Natural killer T cells mediate inflammation in the bile ducts
Mucosal Immunol., 11 (6), 1582-1590
DOI 10.1038/s41385-018-0066-8

Publications 2017

Fickert P, Hirschfield GM, Denk G, Marschall HU, Altorjay I, Farkkila M, Schramm C, Spengler U, Chapman R, Bergquist A, Schrumpf E, Nevens F, Trivedi P, Reiter FP, Tornai I, Halilbasic E, Greinwald R, Prols M, Manns MP, Trauner M, European PSC norUDCA Study Grp (2017)
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
J. Hepatol., 67 (3), 549-558
DOI 10.1016/j.jhep.2017.05.009

Hov JR, Boberg KM, Taraldsrud E, Vesterhus M, Boyadzhieva M, Solberg IC, Schrumpf E, Vatn MH, Lie BA, Molberg O, Karlsen TH (2017)
Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis
Liver Int., 37 (3), 458-465
DOI 10.1111/liv.13238

Kummen M, Holm K, Anmarkrud JA, Nygard S, Vesterhus M, Hoivik ML, Troseid M, Marschall HU, Schrumpf E, Moum B, Rosjo H, Aukrust P, Karlsen TH, Hov JR (2017)
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
Gut, 66 (4), 611-619
DOI 10.1136/gutjnl-2015-310500

Vesterhus M, Holm A, Hov JR, Nygard S, Schrumpf E, Melum E, Thorbjornsen LW, Paulsen V, Lundin K, Dale I, Gilja OH, Zweers SJLB, Vatn M, Schaap FG, Jansen PLM, Ueland T, Rosjo H, Moum B, Ponsioen CY, Boberg KM, Farkkila M, Karlsen TH, Lund-Johansen F (2017)
Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis
J. Hepatol., 66 (6), 1214-1222
DOI 10.1016/j.jhep.2017.01.019

Weismuller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, Holm K, Gotthardt D, Farkkila MA, Marschall HU, Thorburn D, Weersma RK, Fevery J, Mueller T, Chazouilleres O, Schulze K, Lazaridis KN, Almer S, Pereira SP, Levy C, Mason A, Naess S, Bowlus CL, Floreani A, Halilbasic E et al. (2017)
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
Gastroenterology, 152 (8), 1975-+
DOI 10.1053/j.gastro.2017.02.038

Publications 2016

Ponsioen CY, Chapman RW, Chazouilleres O, Hirschfield GM, Karlsen TH, Lohse AW, Pinzani M, Schrumpf E, Trauner M, Gores GJ (2016)
Surrogate Endpoints for Clinical Trials in Primary Sclerosing Cholangitis: Review and Results From an International PSC Study Group Consensus Process
Hepatology, 63 (4), 1357-1367
DOI 10.1002/hep.28256

Publications 2015

Andersen IM, Fosby B, Boberg KM, Clausen OPF, Jebsen P, Melum E, Line PD, Foss A, Schrumpf E, Karlsen TH (2015)
Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway
Transplant. Direct., 1 (9), e39
DOI 10.1097/TXD.0000000000000548

Andresen K, Boberg KM, Vedeld HM, Honne H, Jebsen P, Hektoen M, Wadsworth CA, Clausen OP, Lundin KEA, Paulsen V, Foss A, Mathisen O, Aabakken L, Schrumpf E, Lothe RA, Lind GE (2015)
Four DNA Methylation Biomarkers in Biliary Brush Samples Accurately Identify the Presence of Cholangiocarcinoma
Hepatology, 61 (5), 1651-1659
DOI 10.1002/hep.27707

Fosby B, Melum E, Bjoro K, Bennet W, Rasmussen A, Andersen IM, Castedal M, Olausson M, Wibeck C, Gotlieb M, Gjertsen H, Toivonen L, Foss S, Makisalo H, Nordin A, Sanengen T, Bergquist A, Larsson ME, Soderdahl G, Nowak G, Boberg KM, Isoniemi H, Keiding S, Foss A, Line PD et al. (2015)
Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013
Scand. J. Gastroenterol., 50 (6), 797-808
DOI 10.3109/00365521.2015.1036359

Schrumpf E, Boberg KM, Karlsen TH (2015)
Primary sclerosing cholangitis - the Norwegian experience
Scand. J. Gastroenterol., 50 (6), 781-796
DOI 10.3109/00365521.2015.1028996

Vesterhus M, Hov JR, Holm A, Schrumpf E, Nygard S, Godang K, Andersen IM, Naess S, Thorburn D, Saffioti F, Vatn M, Gilja OH, Lund-Johansen F, Syversveen T, Brabrand K, Pares A, Ponsioen CY, Pinzani M, Farkkila M, Moum B, Ueland T, Rosjo H, Rosenberg W, Boberg KM, Karlsen TH (2015)
Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis
Hepatology, 62 (1), 188-197
DOI 10.1002/hep.27825

Publications 2014

Naess S, Bjornsson E, Anmarkrud JA, Al Mamari S, Juran BD, Lazaridis KN, Chapman R, Bergquist A, Melum E, Marsh SGE, Schrumpf E, Lie BA, Boberg KM, Karlsen TH, Hov JR (2014)
Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease
Liver Int., 34 (10), 1488-1495
DOI 10.1111/liv.12492

Naess S, Lie BA, Melum E, Olsson M, Hov JR, Croucher PJP, Hampe J, Thorsby E, Bergquist A, Traherne JA, Schrumpf E, Boberg KM, Schreiber S, Franke A, Karlsen TH (2014)
Refinement of the MHC Risk Map in a Scandinavian Primary Sclerosing Cholangitis Population
PLoS One, 9 (12), e114486
DOI 10.1371/journal.pone.0114486

Publications 2013

Ellinghaus D, Folseraas T, Holm K, Ellinghaus E, Melum E, Balschun T, Laerdahl JK, Shiryaev A, Gotthardt DN, Weismuller TJ, Schramm C, Wittig M, Bergquist A, Bjornsson E, Marschall HU, Vatn M, Teufel A, Rust C, Gieger C, Wichmann HE, Runz H, Sterneck M, Rupp C, Braun F, Weersma RK et al. (2013)
Genome-Wide Association Analysis in Primary Sclerosing Cholangitis and Ulcerative Colitis Identifies Risk Loci at GPR35 and TCF4
Hepatology, 58 (3), 1074-1083
DOI 10.1002/hep.25977

Jorgensen KK, Lindstrom L, Cvancarova M, Karlsen TH, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM (2013)
Immunosuppression After Liver Transplantation for Primary Sclerosing Cholangitis Influences Activity of Inflammatory Bowel Disease
Clin. Gastroenterol. Hepatol., 11 (5), 517-523
DOI 10.1016/j.cgh.2012.12.027

Kummen M, Schrumpf E, Boberg KM (2013)
Liver abnormalities in bowel diseases
Best Pract. Res. Clin. Gastroenterol., 27 (4), 531-542
DOI 10.1016/j.bpg.2013.06.013

Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismuller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Muller T, Srivastava B, Dalekos G, Nothen MM, Herms S et al. (2013)
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
Nature Genet., 45 (6), 670-+
DOI 10.1038/ng.2616

Publications 2012

Andresen K, Boberg KM, Vedeld HM, Honne H, Hektoen M, Wadsworth CA, Clausen OP, Karlsen TH, Foss A, Mathisen O, Schrumpf E, Lothe RA, Lind GE (2012)
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma
Epigenetics, 7 (11), 1249-1257
DOI 10.4161/epi.22191

Folseraas T, Melum E, Rausch P, Juran BD, Ellinghaus E, Shiryaev A, Laerdahl JK, Ellinghaus D, Schramm C, Weismuller TJ, Gotthard DN, Hov JR, Clausen OP, Weersma RK, Janse M, Boberg KM, Bjornsson E, Marschall HU, Cleynen I, Rosenstiel P, Holm K, Teufel A, Rust C, Gieger C, Wichmann HE et al. (2012)
Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci
J. Hepatol., 57 (2), 366-375
DOI 10.1016/j.jhep.2012.03.031

Jorgensen KK, Grzyb K, Lundin KEA, Clausen OPF, Aamodt G, Schrumpf E, Vatn MH, Boberg KM (2012)
Inflammatory bowel disease in patients with primary sclerosing cholangitis: Clinical characterization in liver transplanted and nontransplanted patients
Inflamm. Bowel Dis., 18 (3), 536-545
DOI 10.1002/ibd.21699

Jorgensen KK, Lindstrom L, Cvancarova M, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM (2012)
Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study
Scand. J. Gastroenterol., 47 (8-9), 1021-1029
DOI 10.3109/00365521.2012.685754

Publications 2011

Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E, Int Autoimmune Hepatitis Grp (2011)
Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue
J. Hepatol., 54 (2), 374-385
DOI 10.1016/j.jhep.2010.09.002

Hov JR, Keitel V, Schrumpf E, Haussinger D, Karlsen TH (2011)
TGR5 Sequence Variation in Primary Sclerosing Cholangitis
Dig. Dis., 29 (1), 78-84
DOI 10.1159/000324138

Hov JR, Kosmoliaptsis V, Traherne JA, Olsson M, Boberg KM, Bergquist A, Schrumpf E, Bradley JA, Taylor CJ, Lie BA, Trowsdale J, Karlsen TH (2011)
Electrostatic Modifications of the Human Leukocyte Antigen-DR P9 Peptide-Binding Pocket and Susceptibility to Primary Sclerosing Cholangitis
Hepatology, 53 (6), 1967-1976
DOI 10.1002/hep.24299

Janse M, Lamberts LE, Franke L, Raychaudhuri S, Ellinghaus E, Boberg KM, Melum E, Folseraas T, Schrumpf E, Bergquist A, Bjornsson E, Fu JY, Westra HJ, Groen HJM, Fehrmann RSN, Smolonska J, van den Berg LH, Ophoff RA, Porte RJ, Weismuller TJ, Wedemeyer J, Schramm C, Sterneck M, Gunther R, Braun F et al. (2011)
Three Ulcerative Colitis Susceptibility Loci Are Associated with Primary Sclerosing Cholangitis and Indicate a Role for IL2, REL, and CARD9
Hepatology, 53 (6), 1977-1985
DOI 10.1002/hep.24307

Melum E, Franke A, Schramm C, Weismuller TJ, Gotthardt DN, Offner FA, Juran BD, Laerdahl JK, Labi V, Bjornsson E, Weersma RK, Henckaerts L, Teufel A, Rust C, Ellinghaus E, Balschun T, Boberg KM, Ellinghaus D, Bergquist A, Sauer P, Ryu E, Hov JR, Wedemeyer J, Lindkvist B, Wittig M et al. (2011)
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci
Nature Genet., 43 (1), 17-19
DOI 10.1038/ng.728

Publications 2010

Hov JR, Keitel V, Laerdahl JK, Spomer L, Ellinghaus E, ElSharawy A, Melum E, Boberg KM, Manke T, Balschun T, Schramm C, Bergquist A, Weismuller T, Gotthardt D, Rust C, Henckaerts L, Onnie CM, Weersma RK, Sterneck M, Teufel A, Runz H, Stiehl A, Ponsioen CY, Wijmenga C, Vatn MH et al. (2010)
Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis
PLoS One, 5 (8), e12403
DOI 10.1371/journal.pone.0012403

Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, Balschun T, Lie BA, Bergquist A, Schramm C, Weismuller TJ, Gotthardt D, Rust C, Philipp EER, Fritz T, Henckaerts L, Weersma RK, Stokkers P, Ponsioen CY, Wijmenga C, Sterneck M, Nothnagel M, Hampe J, Teufel A, Runz H, Rosenstiel P et al. (2010)
Genome-Wide Association Analysis in Primary Sclerosing Cholangitis
Gastroenterology, 138 (3), 1102-1111
DOI 10.1053/j.gastro.2009.11.046

Karlsen TH, Schrumpf E, Boberg KM (2010)
Update on primary sclerosing cholangitis
Dig. Liver Dis., 42 (6), 390-400
DOI 10.1016/j.dld.2010.01.011

Karlsen TH, Schrumpf E, Boberg KM (2010)
Primary sclerosing cholangitis
Best Pract. Res. Clin. Gastroenterol., 24 (5), 655-666
DOI 10.1016/j.bpg.2010.07.005

Ponsioen CY, Reitsma JB, Boberg KM, Aabakken L, Rauws EAJ, Schrumpf E (2010)
Validation of a cholangiographic prognostic model in primary sclerosing cholangitis
Endoscopy, 42 (9), 742-747
DOI 10.1055/s-0030-1255527

Publications 2009

Forsbring M, Vik ES, Dalhus B, Karlsen TH, Bergquist A, Schrumpf E, Bjoras M, Boberg KM, Alseth I (2009)
Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma
Carcinogenesis, 30 (7), 1147-1154
DOI 10.1093/carcin/bgp118

Publications 2008

Karlsen TH, Schrumpf E, Boberg KM (2008)
Gallbladder polyps in primary sclerosing cholangitis: not so benign
Curr. Opin. Gastroenterol., 24 (3), 395-399
DOI 10.1097/MOG.0b013e3282f5727a

Melum E, Karlsen TH, Bergquist A, Schrumpf E, Boberg KM (2008)
An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis
Am. J. Gastroenterol., 103 (4), 1045
DOI 10.1111/j.1572-0241.2007.01772_5.x

Melum E, Karlsen TH, Schrumpf E, Bergquist A, Thorsby E, Boberg KM, Lie BA (2008)
Cholanglocarcinoma in primary sclerosing cholangitis is associated with NKG2D Polymorphisms
Hepatology, 47 (1), 90-96
DOI 10.1002/hep.21964

Publications 2007

Karlsen T, Boberg K, Vatn M, Bergquist A, Hampe J, Schrumpf E, Thorsby E, Schreiber S, Lie BA, IBSEN study grp (2007)
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis
Genes Immun., 8 (3), 275-278
DOI 10.1038/sj.gene.6364377

Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A, Schrumpf E, Thorsby E, Lie BA (2007)
Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis
J. Hepatol., 46 (5), 899-906
DOI 10.1016/j.jhep.2007.01.032

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broome U, Schreiber S, Boberg KM (2007)
Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis
Am. J. Gastroenterol., 102 (1), 115-121
DOI 10.1111/j.1572-0241.2006.00928.x

Karlsen TH, Schrumpf E, Boberg KM (2007)
Genetic epidemiology of primary sclerosing cholangitis
World J. Gastroenterol., 13 (41), 5421-5431
DOI 10.3748/wjg.v13.i41.5421

Wiencke K, Karlsen TH, Boberg KM, Thorsby E, Schrumpf E, Lie BA, Spurkland A (2007)
Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes
Tissue Antigens, 69 (2), 161-169
DOI 10.1111/j.1399-0039.2006.00738.x

Publications 2006

Berstad AE, Aabakken L, Smith HJ, Aasen S, Boberg KM, Schrumpf E (2006)
Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis
Clin. Gastroenterol. Hepatol., 4 (4), 514-520
DOI 10.1016/j.cgh.2005.10.007

Bjoro K, Brandsaeter B, Foss A, Schrumpf E (2006)
Liver transplantation in primary sclerosing cholangitis
Semin. Liver Dis., 26 (1), 69-79
DOI 10.1055/s-2006-933565

Boberg KM, Foss A, Midtvedt K, Schrumpf E (2006)
ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody
Clin. Transplant., 20 (2), 265-268
DOI 10.1111/j.1399-0012.2005.00470.x

Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E (2006)
Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis
J. Hepatol., 45 (4), 568-574
DOI 10.1016/j.jhep.2006.05.010

Bowlus CL, Karlsen TH, Broome U, Thorsby E, Vatn M, Schrumpf E, Lie BA, Boberg KM, IBSEN study grp (2006)
Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis
J. Hepatol., 45 (5), 704-710
DOI 10.1016/j.jhep.2006.03.012

Karlsen TH, Lie BA, Froslie KF, Thorsby E, Broome U, Schrumpf E, Boberg KM (2006)
Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis
Gastroenterology, 131 (3), 781-787
DOI 10.1053/j.gastro.2006.05.057

Melum E, Karlsen TH, Broome U, Thorsby E, Schrumpf E, Boberg KM, Lie BA (2006)
The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta 32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients
Tissue Antigens, 68 (1), 78-81
DOI 10.1111/j.1399-0039.2006.00604.x

Melum E, Schrumpf E, Bjoro K (2006)
Liver TX for hepatitis C cirrhosis in a low prevalence population: Risk factors and status at evaluation
Scand. J. Gastroenterol., 41 (5), 592-596
DOI 10.1080/00365520500347113

Wiencke K, Boberg KM, Donaldson P, Harbo H, Ling V, Schrumpf E, Spurkland A (2006)
No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis
Scand. J. Gastroenterol., 41 (5), 586-591
DOI 10.1080/00365520500377870

Publications 2005

Boberg KM, Schrumpf E (2005)
Prognosis of autoimmune liver diseases
FALK SYMP, 142, 233-246

Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Kirkegaard P, Friman S, Bjoro K, Schrumpf E, Nordic Liver Transplantation Grp (2005)
Chernopreventive effect of ursodeoxycholic acid in primary sclerosing cholangitis?
FALK SYMP, 141, 242-249

Brandsaeter B, Schrumpf E, Bentdal O, Brabrand K, Smith HJ, Abildgaard A, Clausen OP, Bjoro K (2005)
Recurrent primary sclerosing cholangitis after liver transplantation: A magnetic resonance cholanglography study with analyses of predictive factors
Liver Transplant., 11 (11), 1361-1369
DOI 10.1002/lt.20444

Schrumpf E, Boberg KM (2005)
Standard treatment for primary sclerosing cholangitis and overlap autoimmune hepatitis/primary sclerosing cholangitis
FALK SYMP, 142, 203-207

Publications 2004

Bjoro K, Schrumpf E (2004)
Liver transplantation for primary sclerosing cholangitis
J. Hepatol., 40 (4), 570-577
DOI 10.1016/j.jhep.2004.01.021

Boberg KM, Clausen ORF, Schrumpf E (2004)
Primary sclerosing cholangitis: diagnosis and differential diagnosis
FALK SYMP, 136, 203-217

Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Kirkegaard P, Friman S, Bjorol K (2004)
Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy
J. Hepatol., 40 (5), 815-822
DOI 10.1016/j.jhep.2004.01.002

Schrumpf E, Boberg KM (2004)
Primary sclerosing cholangitis and inflammatory bowel disease: when and how do they relate to each other?
FALK SYMP, 136, 283-288

Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM, IBSEN study grp (2004)
Association of matrix metalloproteinase-1 and-3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients
J. Hepatol., 41 (2), 209-214
DOI 10.1016/j.jhep.2004.04.024

Publications 2003

Bjoro K, Brandsaeter B, Wiencke K, Bjoro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
Scand. J. Gastroenterol., 38 (3), 320-327
DOI 10.1080/00365520310000681

Bjøro K, Brandsæter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
In Scandinavian journal of gastroenterology, Taylor & Francis, Basingstoke, 38(2003)3, s.320-7
BIBSYS 041707508

Boberg KM, Egeland T, Schrumpf E (2003)
Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients
Scand. J. Gastroenterol., 38 (9), 991-995
DOI 10.1080/00365520310005172

Boberg KM, Jebsen P, Clausen OP, Aabakken L, Brekke I, Schrumpf E (2003)
Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation
J. Hepatol., 39 (3), 453
DOI 10.1016/S0168-8278(03)00326-X

Brandsaeter B, Friman S, Broome U, Isoniemi H, Olausson M, Backman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Kirkegaard P, Bjoro K (2003)
Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries
Scand. J. Gastroenterol., 38 (11), 1176-1183
DOI 10.1080/00365520310006009

Brandsater B, Broome U, Isoniemi H, Friman S, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Olsson R, Olausson M, Kirkegaard P, Bjoro K (2003)
Liver transplantation for primary sclerosing cholangitis in the Nordic countries: Outcome after acceptance to the waiting list
Liver Transplant., 9 (9), 961-969
DOI 10.1053/jlts.2003.50169

Schrumpf E, Boberg KM (2003)
Hepatic and extrahepatic malignancies and primary sclerosing cholangitis
Gut, 52 (2), 165
DOI 10.1136/gut.52.2.165

Publications 2002

Bjornsson E, Boberg KM, Cullen S, Fleming K, Clausen OP, Fausa O, Schrumpf E, Chapman RW (2002)
Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis
Gut, 51 (5), 731-735
DOI 10.1136/gut.51.5.731

Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broome U, Chapman R, Fausa O, Egeland T, Rocca G, Schrumpf E (2002)
Cholangiocarcinoma in primary sclerosing cholangitis: Risk factors and clinical presentation
Scand. J. Gastroenterol., 37 (10), 1205-1211
DOI 10.1080/003655202760373434

Boberg KM, Rocca G, Egeland T, Bergquist A, Broome U, Caballeria L, Chapman R, Hultcrantz R, Mitchell S, Pares A, Rosina F, Schrumpf E (2002)
Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis
Hepatology, 35 (3), 652-657
DOI 10.1053/jhep.2002.31872

Schrumpf E, Boberg KM (2002)
Endoscopic treatment for primary sclerosing cholangitis?
J. Hepatol., 36 (2), PII S0168-8278(01)00292-6-279
DOI 10.1016/S0168-8278(01)00292-6

Publications 2001

Bjoro K, Kirkegaard P, Ericzon BG, Friman S, Schrumpf E, Isoniemi H, Herlenius G, Olausson M, Rasmussen A, Foss A, Hockerstedt K (2001)
Is a 3-day limit for highly urgent liver transplantation for fulminant hepatic failure appropriate, and is the diagnosis in some cases incorrect?
Transplant. Proc., 33 (4), 2511-2513
DOI 10.1016/S0041-1345(01)02080-2

Boberg KM, Spurkland A, Rocca G, Egeland T, Saarinen S, Mitchell S, Broome U, Chapman R, Olerup O, Pares A, Rosina F, Schrumpf E (2001)
The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis
Scand. J. Gastroenterol., 36 (8), 886-890
DOI 10.1080/003655201750313441

Leidenius M, Hockerstedt K, Broome U, Ericzon BG, Friman S, Olausson M, Schrumpf E (2001)
Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study
J. Hepatol., 34 (6), 792-798
DOI 10.1016/S0168-8278(01)00042-3

Mitchell SA, Grove J, Spurkland A, Boberg KM, Fleming KA, Day CP, Schrumpf E, Chapman RW, European Study Grp Primary Scleros (2001)
Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis
Gut, 49 (2), 288-294
DOI 10.1136/gut.49.2.288

Offstad J, Schrumpf E, Geiran O, Soreide O, Simonsen S (2001)
Plasma exchange and heart-liver transplantation in a patient with homozygous familial hypercholesterolemia
Clin. Transplant., 15 (6), 432-436
DOI 10.1034/j.1399-0012.2001.150612.x

Schrumpf E, Boberg KM (2001)
Epidemiology of primary sclerosing cholangitis
Best Pract. Res. Clin. Gastroenterol., 15 (4), 553-562
DOI 10.1053/bega.2001.0204

Wiencke K, Spurkland A, Schrumpf E, Boberg KM (2001)
Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles
Hepatology, 34 (4), 625-630
DOI 10.1053/jhep.2001.27543

Publications 2000

Boberg KM, Schrumpf E, Bergquist A, Broome U, Pares A, Remotti H, Schjolberg A, Spurkland A, Clausen OPF (2000)
Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development
J. Hepatol., 32 (3), 374-380
DOI 10.1016/S0168-8278(00)80386-4

Schrumpf E, Boberg KM (2000)
Primary sclerosing cholangitis: challenges of a new millenium
Dig. Liver Dis., 32 (9), 753-755
DOI 10.1016/S1590-8658(00)80350-3

Publications 1999

Bjoro K, Friman S, Hockerstedt K, Kirkegaard P, Keiding S, Schrumpf E, Olausson M, Oksanen A, Isoniemi H, Hjortrup A, Bergan A, Ericzon BG (1999)
Liver transplantations in the Nordic countries, 1982-1998: Changes of indications and improving results
Scand. J. Gastroenterol., 34 (7), 714-722

Boberg KM, Brosstad F, Egeland T, Egge T, Schrumpf E (1999)
Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy?
Thromb. Haemost., 81 (3), 378-381

Giercksky T, Boberg KM, Farstad LN, Halvorsen S, Schrumpf E (1999)
Severe liver failure in exertional heat stroke
Scand. J. Gastroenterol., 34 (8), 824-827

Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, Ciusani E, Chapman R, Ercilla G, Fausa O, Knutsen I, Pares A, Rosina F, Olerup O, Thorsby E, Schrumpf E (1999)
HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations
Tissue Antigens, 53 (5), 459-469
DOI 10.1034/j.1399-0039.1999.530502.x

Publications 1998

Bjoro K, Gjerstad L, Bentdal O, Osnes S, Schrumpf E (1998)
Topiramate and fulminant liver failure
Lancet, 352 (9134), 1119

Bjoro K, Schrumpf E, Bergan A, Haaland T, Skaug K, Froland SS (1998)
Liver transplantation for endstage hepatitis C cirrhosis in a patient with primary hypogammaglobulinaemia
Scand. J. Infect. Dis., 30 (5), 520-522

Publications 1997

Nordoy I, Krarup HB, Bell H, Christensen PB, Elgjo K, Von der Lippe B, De Muckadell OS, Maeland A, Ring-Larsen H, Samdal HH, Simmonds P, Skaug K, Tage-Jensen U, Schrumpf E (1997)
Interferon-alpha 2b therapy in low-activity hepatitis C: A pilot study
Scand. J. Gastroenterol., 32 (12), 1256-1260
DOI 10.3109/00365529709028156

Publications 1996

Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, Schrumpf E (1996)
Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis
Hepatology, 23 (6), 1369-1376
DOI 10.1053/jhep.1996.v23.pm0008675153

Publications 1995

BJORO K, KRARUP H, BELL H, CHRISTOPHERSEN P, EVENSEN S, FROLAND SS, LAURSEN A, VANDERLIPPE B, MAELAND A, RANEK L, RINGLARSEN H, SCHOU G, SCHRUMPF E, TYGSTRUP N (1995)
2 DOSE REGIMENS OF RECOMBINANT INTERFERON-ALPHA-2B IN CHRONIC HEPATITIS-C VIRUS-INFECTION - BIOCHEMISTRY, HEPATITIS-C VIRUS RNA, AND LIVER HISTOLOGY AS RESPONSE INDICES
Scand. J. Gastroenterol., 30 (11), 1119-1124
DOI 10.3109/00365529509101617

BJORO K, SCHRUMPF E, ELGJO K, KOLMANSKOG F (1995)
MONSTROUS ASCITES IN HEREDITARY HEMORRHAGIC TELANGIECTASIA
Scand. J. Gastroenterol., 30 (1), 92-94
DOI 10.3109/00365529509093242

JACOBSEN MB, HANSSEN LE, KOLMANNSKOG F, SCHRUMPF E, VATN MH, BERGAN A (1995)
INTERFERON-ALPHA-2B, WITH OR WITHOUT PRIOR HEPATIC-ARTERY EMBOLIZATION - CLINICAL-RESPONSE AND SURVIVAL IN MIDGUT CARCINOID PATIENTS - THE NORWEGIAN CARCINOID STUDY
Scand. J. Gastroenterol., 30 (8), 789-796
DOI 10.3109/00365529509096329

Aaseth J, Thomassen Y, Aadland E, Fausa O, Schrumpf E (1995)
Hepatic retention of copper and selenium in primary sclerosing cholangitis
Scand. J. Gastroenterol., 30 (12), 1200-1203
DOI 10.3109/00365529509101631

Publications 1994

BOBERG KM, LUNDIN KEA, SCHRUMPF E (1994)
ETIOLOGY AND PATHOGENESIS IN PRIMARY SCLEROSING CHOLANGITIS
Scand. J. Gastroenterol., 29 204, 47-58
DOI 10.3109/00365529409103625

BOBERG KM, SCHRUMPF E, FAUSA O, ELGJO K, KOLMANNSKOG F, HAALAND T, HOLTER E (1994)
HEPATOBILIARY DISEASE IN ULCERATIVE-COLITIS - AN ANALYSIS OF 18 PATIENTS WITH HEPATOBILIARY LESIONS CLASSIFIED AS SMALL-DUCT PRIMARY SCLEROSING CHOLANGITIS
Scand. J. Gastroenterol., 29 (8), 744-752
DOI 10.3109/00365529409092504

HOCKERSTEDT K, ISONIEMI H, ERICZON BG, BROOME U, FRIMAN S, PERSSON H, BERGAN A, SCHRUMPF E, KIRKEGAARD P, HJORTRUP A, KEIDING S (1994)
IS A 3-DAY WAITING LIST APPROPRIATE FOR PATIENTS WITH ACUTE LIVER-FAILURE
Transplant. Proc., 26 (3), 1786-1787

KOLMANNSKOG F, JAKOBSEN JA, SCHRUMPF E, BERGEN A (1994)
DUPLEX-DOPPLER SONOGRAPHY AND ANGIOGRAPHY IN THE EVALUATION FOR LIVER-TRANSPLANTATION
Acta Radiol., 35 (1), 1-5

NORDOY I, SCHRUMPF E, ELGJO K, FLESLAND O, GLENDE JA, ORJASAETER H, SIEBKE JC (1994)
LIVER-DISEASE IN ANTI-HEPATITIS-C VIRUS-POSITIVE NORWEGIAN BLOOD-DONORS
Scand. J. Gastroenterol., 29 (1), 77-81
DOI 10.3109/00365529409090441

SCHRUMPF E, ABDELNOOR M, FAUSA O, ELGJO K, JENSSEN E, KOLMANNSKOG F (1994)
RISK-FACTORS IN PRIMARY SCLEROSING CHOLANGITIS
J. Hepatol., 21 (6), 1061-1066
DOI 10.1016/S0168-8278(05)80618-X

VETVIK K, SCHRUMPF E, MOWINCKEL P, AASE S, ANDERSEN KJ (1994)
EFFECTS OF OMEPRAZOLE AND ERADICATION OF HELICOBACTER-PYLORI ON GASTRIC AND DUODENAL MUCOSAL ENZYME-ACTIVITIES AND DNA IN DUODENAL-ULCER PATIENTS
Scand. J. Gastroenterol., 29 (11), 995-1000
DOI 10.3109/00365529409094876

Publications 1993

SCHRUMPF E (1993)
THE VIEW CONCERNING INDUSTRIAL CHILD LABOR - AN END TO THE MISERY READING
Hist. Tidsskr., 72 (2), 209-222

Publications 1992

SOREIDE O, BERSTAD T, BAKKA A, SCHRUMPF E, HANSSEN LE, ENGH V, BERGAN A, FLATMARK A (1992)
SURGICAL-TREATMENT AS A PRINCIPLE IN PATIENTS WITH ADVANCED ABDOMINAL CARCINOID-TUMORS
Surgery, 111 (1), 48-54

ZAULI D, BAFFONI L, CASSANI F, FUSCONI M, LENZI M, BALLARDINI G, LUIGI M, BIANCHI FB, SCHRUMPF E (1992)
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS, ULCERATIVE-COLITIS, AND AUTOIMMUNE-DISEASES
Gastroenterology, 102 (3), 1088-1089
DOI 10.1016/0016-5085(92)90213-I

Publications 1991

ASPESTRAND F, SCHRUMPF E, JACOBSEN M, HANSSEN L, ENDRESEN K (1991)
INCREASED LYMPHATIC FLOW FROM THE LIVER IN DIFFERENT INTRAHEPATIC AND EXTRAHEPATIC DISEASES DEMONSTRATED BY CT
J. Comput. Assist. Tomogr., 15 (4), 550-554
DOI 10.1097/00004728-199107000-00004

BENDSTEN F, CHRISTENSEN E, HARDT F, HENRIKSEN JH, JUHL E, MATZEN P, RINGLARSEN H, SORENSEN TIA, ELSBORG L, ERIKSEN J, HAMBERG O, LINDAHL F, SANCHEZ G, DEMUCKADELL OS, SCHLICHTING P, SCHRUMPF E, SKOVBJERG H, WALMER I, ANDERSON PK, BILLEBRAHE NE, BONDESEN S, BURCHARTH F, FALLINGBORG J, FAUSA O, FREUND L et al. (1991)
PROPHYLAXIS OF 1ST HEMORRHAGE FROM ESOPHAGEAL-VARICES BY SCLEROTHERAPY, PROPRANOLOL OR BOTH IN CIRRHOTIC-PATIENTS - A RANDOMIZED MULTICENTER TRIAL
Hepatology, 14 (6), 1016-1024

FAUSA O, SCHRUMPF E, ELGJO K (1991)
RELATIONSHIP OF INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS
Semin. Liver Dis., 11 (1), 31-39
DOI 10.1055/s-2008-1040420

FUNK J, LANGELAND T, SCHRUMPF E, HANSSEN LE (1991)
PSORIASIS INDUCED BY INTERFERON-ALPHA
Br. J. Dermatol., 125 (5), 463-465
DOI 10.1111/j.1365-2133.1991.tb14774.x

HAGVE TA, MYRSETH LE, SCHRUMPF E, BLOMHOFF JP, CHRISTOPHERSEN B, ELGJO K, GJONE E, PRYDZ H (1991)
LIVER STEATOSIS IN HYPOBETALIPOPROTEINEMIA - A CASE-REPORT
J. Hepatol., 13 (1), 104-111
DOI 10.1016/0168-8278(91)90871-8

HANSSEN LE, SCHRUMPF E, JACOBSEN MB, KOLBENSTVEDT AN, KOLMANNSKOG F, BERGAN A, DOLVA LO (1991)
EXTENDED EXPERIENCE WITH RECOMBINANT ALPHA-2B INTERFERON WITH OR WITHOUT HEPATIC-ARTERY EMBOLIZATION IN THE TREATMENT OF MIDGUT CARCINOID-TUMORS - A PRELIMINARY-REPORT
Acta Oncol., 30 (4), 523-527
DOI 10.3109/02841869109092412

KOLMANNSKOG F, KOLBENSTVEDT AN, SCHRUMPF E, HANSSEN LE (1991)
SIDE-EFFECTS AND COMPLICATIONS AFTER HEPATIC-ARTERY EMBOLIZATION IN THE CARCINOID-SYNDROME
Scand. J. Gastroenterol., 26 (5), 557-562
DOI 10.3109/00365529108998580

VETVIK K, SCHRUMPF E, ANDERSEN KJ, SKAGEN DW, HALVORSEN OJ (1991)
EFFECT OF MISOPROSTOL AND ANTACIDS ON GASTRIC AND DUODENAL MUCOSAL ENZYME-ACTIVITIES IN DUODENAL-ULCER PATIENTS
Scand. J. Gastroenterol., 26 (4), 385-391
DOI 10.3109/00365529108996499

Publications 1990

BELL H, SCHRUMPF E, FAGERHOL MK (1990)
HETEROZYGOUS MZ ALPHA-1-ANTITRYPSIN DEFICIENCY IN ADULTS WITH CHRONIC LIVER-DISEASE
Scand. J. Gastroenterol., 25 (8), 788-792
DOI 10.3109/00365529008999216

HAUKENES G, MATRE R, TONDER O, MYRMEL H, SCHRUMPF E (1990)
MEASLES AND RUBELLA ANTIBODIES IN PATIENTS WITH CHRONIC LIVER-DISEASE
J. Hepatol., 11 (3), 389
DOI 10.1016/0168-8278(90)90228-J

HOCKERSTEDT K, ERICZON BG, ERIKSSON LS, FLATMARK A, ISONIEMI H, KARLBERG I, KEIDING N, KEIDING S, OLSSON R, SAMELA K, SCHRUMPF E, SODERMAN C (1990)
SURVIVAL AFTER LIVER-TRANSPLANTATION FOR PRIMARY BILIARY-CIRRHOSIS - USE OF PROGNOSTIC INDEXES FOR COMPARISON WITH MEDICAL-TREATMENT
Transplant. Proc., 22 (4), 1499-1500

JACOBSEN MB, FAUSA O, ELGJO K, SCHRUMPF E (1990)
HEPATIC-LESIONS IN ADULT CELIAC-DISEASE
Scand. J. Gastroenterol., 25 (7), 656-662
DOI 10.3109/00365529008997589

KEIDING S, ERICZON BG, ERIKSSON S, FLATMARK A, HOCKERSTEDT K, ISONIEMI H, KARLBERG I, KEIDING N, OLSSON R, SAMELA K, SCHRUMPF E, SODERMAN C (1990)
SURVIVAL AFTER LIVER-TRANSPLANTATION OF PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS IN THE NORDIC COUNTRIES - COMPARISON WITH EXPECTED SURVIVAL IN ANOTHER SERIES OF TRANSPLANTATIONS AND IN AN INTERNATIONAL TRIAL OF MEDICAL-TREATMENT
Scand. J. Gastroenterol., 25 (1), 11-18
DOI 10.3109/00365529008999204

RYDNING A, SCHRUMPF E, ABDELNOOR M, ELGJO K, JENSSEN E (1990)
FACTORS OF PROGNOSTIC IMPORTANCE IN PRIMARY BILIARY-CIRRHOSIS
Scand. J. Gastroenterol., 25 (2), 119-126
DOI 10.3109/00365529009107932

SCHRUMPF E, ELGJO K, FAUSA O, HAUKENES G, KVALE D, ROLLAG H (1990)
THE SIGNIFICANCE OF ANTI-HEPATITIS-C VIRUS-ANTIBODIES MEASURED IN CHRONIC LIVER-DISEASE
Scand. J. Gastroenterol., 25 (11), 1169-1174
DOI 10.3109/00365529008998550

VETVIK K, SCHRUMPF E, ANDERSEN KJ, BORKJE B, ODEGAARD S, SKAGEN DW, HALVORSEN OJ (1990)
ENZYME-ACTIVITIES IN THE GASTRIC-MUCOSA IN DUODENAL-ULCER PATIENTS
Scand. J. Gastroenterol., 25 (6), 594-600
DOI 10.3109/00365529009095535

VETVIK K, SCHRUMPF E, ANDERSEN KJ, SKAGEN DW, HALVORSEN OJ (1990)
EFFECT OF RANITIDINE ON GASTRIC AND DUODENAL MUCOSAL ENZYME-ACTIVITIES IN DUODENAL-ULCER PATIENTS
Scand. J. Gastroenterol., 25 (11), 1123-1128
DOI 10.3109/00365529008998544

Publications 1989

HANSSEN LE, SCHRUMPF E, KOLBENSTVEDT AN, TAUSJO J, DOLVA LO (1989)
RECOMBINANT ALPHA-2-INTERFERON WITH OR WITHOUT HEPATIC-ARTERY EMBOLIZATION IN THE TREATMENT OF MIDGUT CARCINOID-TUMORS - A PRELIMINARY-REPORT
Acta Oncol., 28 (3), 439-443
DOI 10.3109/02841868909111219

HANSSEN LE, SCHRUMPF E, KOLBENSTVEDT AN, TAUSJO J, DOLVA LO (1989)
TREATMENT OF MALIGNANT METASTATIC MIDGUT CARCINOID-TUMORS WITH RECOMBINANT HUMAN ALPHA-2B INTERFERON WITH OR WITHOUT PRIOR HEPATIC-ARTERY EMBOLIZATION
Scand. J. Gastroenterol., 24 (7), 787-795
DOI 10.3109/00365528909089215

HAUG K, SCHRUMPF E, HALVORSEN JF, FLUGE G, HAMRE E, HAMRE T, SKJOLLINGSTAD R (1989)
EPIDEMIOLOGY OF CROHNS-DISEASE IN WESTERN NORWAY
Scand. J. Gastroenterol., 24 (10), 1271-1275
DOI 10.3109/00365528909090798

KALLAND KH, ENDRESEN C, HAUKENES G, SCHRUMPF E (1989)
MEASLES-SPECIFIC NUCLEOTIDE-SEQUENCES AND AUTOIMMUNE CHRONIC ACTIVE HEPATITIS
Lancet, 1 (8651), 1390-1391

VETVIK K, SCHRUMPF E, ANDERSEN KJ, BORKJE B, SKAGEN DW, HALVORSEN OJ (1989)
ENZYME-ACTIVITIES IN THE DUODENAL MUCOSA IN DUODENAL-ULCER PATIENTS
Scand. J. Gastroenterol., 24 (2), 244-250
DOI 10.3109/00365528909093042

Publications 1988

HAUG K, SCHRUMPF E, BARSTAD S, FLUGE G, HALVORSEN JF (1988)
EPIDEMIOLOGY OF ULCERATIVE-COLITIS IN WESTERN NORWAY
Scand. J. Gastroenterol., 23 (5), 517-522
DOI 10.3109/00365528809093904

SCHRUMPF E, FAUSA O, ELGJO K, KOLMANNSKOG F (1988)
HEPATOBILIARY COMPLICATIONS OF INFLAMMATORY BOWEL-DISEASE
Semin. Liver Dis., 8 (3), 201-209
DOI 10.1055/s-2008-1040541

Publications 1987

BORKJE B, HOSTMARK J, SKAGEN DW, SCHRUMPF E, LAERUM OD (1987)
FLOW-CYTOMETRY OF BIOPSY SPECIMENS FROM ULCERATIVE-COLITIS, COLORECTAL ADENOMAS, AND CARCINOMAS
Scand. J. Gastroenterol., 22 (10), 1231-1237
DOI 10.3109/00365528708996469

BORKJE B, LAERUM OD, SCHRUMPF E (1987)
ENZYME-ACTIVITIES IN BIOPSY SPECIMENS FROM LARGE-BOWEL MUCOSA IN ULCERATIVE-COLITIS
Scand. J. Gastroenterol., 22 (4), 443-448
DOI 10.3109/00365528708991488

BORKJE B, LAERUM OD, SCHRUMPF E (1987)
ENZYME-ACTIVITIES IN BIOPSY SPECIMENS FROM LARGE-BOWEL MUCOSA IN COLORECTAL ADENOMAS AND CARCINOMAS
Scand. J. Gastroenterol., 22 (5), 533-538
DOI 10.3109/00365528708991893

HAFFNER J, LINNESTAD P, SCHRUMPF E, HANSSEN LE, FLATEN O, OYASAETER S (1987)
THE IMMEDIATE EFFECT OF HUMAN RENAL-TRANSPLANTATION ON BASAL AND MEAL-STIMULATED LEVELS OF GASTROINTESTINAL HORMONES
Scand. J. Gastroenterol., 22 (1), 42-46
DOI 10.3109/00365528708991854

KVALE D, SCHRUMPF E, BRANDTZAEG P, SOLBERG HE, FAUSA O, ELGJO K (1987)
CIRCULATING SECRETORY IMMUNOGLOBULINS OF THE A-ISOTYPE AND M-ISOTYPE IN CHRONIC LIVER-DISEASE
J. Hepatol., 4 (2), 229-235
DOI 10.1016/S0168-8278(87)80085-5

LINNESTAD P, HANSSEN LE, SCHRUMPF E, SLETTEBO M, OYASAETER S (1987)
DIMINUTION OF POSTPRANDIAL RELEASE OF PANCREATIC-POLYPEPTIDE IN MYOTONIC-DYSTROPHY
Acta Neurol. Belg., 87 (2), 66-69

ODEGAARD S, HOSTMARK J, SKAGEN DW, SCHRUMPF E, LAERUM OD (1987)
FLOW CYTOMETRIC DNA STUDIES IN NORMAL HUMAN GASTRIC-MUCOSA, GASTRITIS, AND RESECTED STOMACHS
Scand. J. Gastroenterol., 22 (6), 750-756

ODEGAARD S, HOSTMARK J, SKAGEN DW, SCHRUMPF E, LAERUM OD (1987)
FLOW CYTOMETRIC DNA STUDIES IN HUMAN GASTRIC-CANCER AND POLYPS
Scand. J. Gastroenterol., 22 (10), 1270-1276
DOI 10.3109/00365528708996475

SCHRUMPF E, FAUSA O, AADLAND E (1987)
PRIMARY SCLEROSING CHOLANGITIS
Scand. J. Gastroenterol., 22 (6), 641-643
DOI 10.3109/00365528709011136

ZAULI D, SCHRUMPF E, CRESPI C, CASSANI F, FAUSA O, AADLAND E (1987)
AN AUTOANTIBODY PROFILE IN PRIMARY SCLEROSING CHOLANGITIS
J. Hepatol., 5 (1), 14-18
DOI 10.1016/S0168-8278(87)80055-7

AADLAND E, SCHRUMPF E, FAUSA O, ELGJO K, HEILO A, AAKHUS T, GJONE E (1987)
PRIMARY SCLEROSING CHOLANGITIS - A LONG-TERM FOLLOW-UP-STUDY
Scand. J. Gastroenterol., 22 (6), 655-664
DOI 10.3109/00365528709011139

Publications 1986

BORKJE B, ODEGAARD S, SKAGEN DW, ANDERSEN KJ, SCHRUMPF E (1986)
ENZYME-ACTIVITIES IN BIOPSY SPECIMENS FROM HUMAN GASTRIC-MUCOSA
Scand. J. Gastroenterol., 21 (9), 1051-1057
DOI 10.3109/00365528608996419

BORKJE B, SKAGEN DW, ANDERSEN KJ, SCHRUMPF E (1986)
LONGITUDINAL DISTRIBUTION OF MUCOSAL ENZYMES IN THE HUMAN LARGE-BOWEL
Scand. J. Gastroenterol., 21 (8), 919-927
DOI 10.3109/00365528608996396

FLATMARK A, BERGAN A, SODAL G, SCHRUMPF E, KVITTINGEN EA, JELLUM E, HALVORSEN S (1986)
DOES LIVER-TRANSPLANTATION CORRECT THE METABOLIC DEFECT IN HEREDITARY TYROSINEMIA
Transplant. Proc., 18 (1), 67-68

KVITTINGEN EA, JELLUM E, STOKKE O, FLATMARK A, BERGAN A, SODAL G, HALVORSEN S, SCHRUMPF E, GJONE E (1986)
LIVER-TRANSPLANTATION IN A 23-YEAR-OLD TYROSINEMIA PATIENT - EFFECTS ON THE RENAL TUBULAR DYSFUNCTION
J. Inherit. Metab. Dis., 9 (2), 216-224
DOI 10.1007/BF01799465

ODEGAARD S, BORKJE B, SKAGEN DW, LAERUM OD, SCHRUMPF E (1986)
ENZYME-ACTIVITIES IN HUMAN GASTRIC-CANCER AND POLYPS
Scand. J. Gastroenterol., 21 (10), 1250-1256
DOI 10.3109/00365528608996451

ODEGAARD S, BORKJE B, SKAGEN DW, LAERUM OD, SCHRUMPF E (1986)
ENZYME-ACTIVITIES IN HUMAN GASTRIC-MUCOSA IN GASTRITIS AND RESECTED STOMACHS
Scand. J. Gastroenterol., 21 (10), 1257-1264
DOI 10.3109/00365528608996452

SCHRUMPF E, STRAY N, FLATMARK A (1986)
TREATMENT OF BLEEDING ESOPHAGEAL-VARICES
Scand. J. Gastroenterol., 21 (8), 897-899
DOI 10.3109/00365528608996392

Publications 1985

BORKJE B, VETVIK K, ODEGAARD S, SCHRUMPF E, LARSSEN TB, KOLMANNSKOG F (1985)
CHRONIC-PANCREATITIS IN PATIENTS WITH SCLEROSING CHOLANGITIS AND ULCERATIVE-COLITIS
Scand. J. Gastroenterol., 20 (4), 539-542

SCHRUMPF E, BERGAN A, DJOSELAND O, FAUSA O, FLATEN O, SKAGEN DW, TRONIER B (1985)
THE EFFECT OF GASTRIC BYPASS OPERATION ON GLUCOSE-TOLERANCE IN OBESITY
Scand. J. Gastroenterol., 20 107, 24-31
DOI 10.3109/00365528509099748

SKREDE S, SOLBERG HE, RITLAND S, BLOMHOFF JP, SCHRUMPF E, ELGJO K (1985)
FOLLOW-UP AND PROSPECTIVE STUDIES OF THE CLASSIFICATION OF LIVER-DISEASE
Scand. J. Gastroenterol., 20 107, 40-51
DOI 10.3109/00365528509099751

Publications 1984

GULDVOG I, LINNESTAD P, SCHRUMPF E, BERSTAD A (1984)
DOPAMINERGIC AND ADRENERGIC INFLUENCE ON GASTRIC-ACID AND PEPSIN-SECRETION STIMULATED BY FOOD - THE ROLE OF VAGAL INNERVATION
Scand. J. Gastroenterol., 19 89, 113-116

Publications 1983

LINNESTAD P, ERICHSEN A, FAUSA O, FLATEN O, HANSSEN LE, SCHRUMPF E (1983)
THE RELEASE OF HUMAN PANCREATIC-POLYPEPTIDE, GASTRIN, GASTRIC-INHIBITORY POLYPEPTIDE, AND SOMATOSTATIN IN CELIAC-DISEASE RELATED TO THE HISTOLOGICAL APPEARANCE OF JEJUNAL MUCOSA BEFORE AND 1 YEAR AFTER GLUTEN WITHDRAWAL
Scand. J. Gastroenterol., 18 (2), 169-175
DOI 10.3109/00365528309181579

LINNESTAD P, GULDVOG I, SCHRUMPF E (1983)
EFFECTS OF DOPAMINE AND DOPAMINE ANTAGONISTS ON POSTPRANDIAL RELEASE OF PANCREATIC-POLYPEPTIDE IN DOGS AND IN HEALTHY-VOLUNTEERS
Scand. J. Gastroenterol., 18 (1), 81-85
DOI 10.3109/00365528309181563

LINNESTAD P, GULDVOG I, SCHRUMPF E (1983)
THE EFFECT OF ALPHA-ADRENERGIC AND BETA-ADRENERGIC AGONISTS AND BLOCKERS ON POSTPRANDIAL PANCREATIC-POLYPEPTIDE RELEASE IN DOGS
Scand. J. Gastroenterol., 18 (1), 87-90
DOI 10.3109/00365528309181564

LINNESTAD P, GULDVOG I, SCHRUMPF E (1983)
THE EFFECT OF HISTAMINE, H1-AGONIST AND H2-AGONIST, AND H1-ANTAGONIST AND H2-ANTAGONIST ON POSTPRANDIAL PANCREATIC-POLYPEPTIDE RELEASE IN DOGS
Scand. J. Gastroenterol., 18 (2), 165-168
DOI 10.3109/00365528309181578

LINNESTAD P, SCHRUMPF E (1983)
PANCREATIC-POLYPEPTIDE RELEASE STIMULATED BY FOOD, SECRETIN AND CHOLECYSTOKININ IN CHRONIC-PANCREATITIS
Scand. J. Gastroenterol., 18 (3), 385-389
DOI 10.3109/00365528309181611

TALSETH T, SCHRUMPF E, ULRICHSEN H (1983)
ACUTE EFFECTS OF INTRAVENOUS CIMETIDINE UPON GASTRIC-SECRETION IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
Nephron, 33 (4), 244-247
DOI 10.1159/000182961

VATN MH, SCHRUMPF E, TALSETH T (1983)
EFFECT OF CIMETIDINE ON INTRINSIC-FACTOR SECRETION STIMULATED BY DIFFERENT DOSES OF PENTAGASTRIN IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
Scand. J. Gastroenterol., 18 (8), 1109-1114
DOI 10.3109/00365528309181849

Publications 1982

BRINCH L, TEISBERG P, SCHRUMPF E, AKESSON I (1982)
THE INVIVO METABOLISM OF C-3 IN HEPATOBILIARY DISEASE ASSOCIATED WITH ULCERATIVE-COLITIS
Scand. J. Gastroenterol., 17 (4), 523-527
DOI 10.3109/00365528209182243

DOLVA LO, HANSSEN KF, FLATEN O, SKARE S, SCHRUMPF E (1982)
EFFECT OF THYROTROPIN-RELEASING-HORMONE ON GASTRIC-ACID SECRETION IN MAN
Scand. J. Gastroenterol., 17 (6), 775-780
DOI 10.3109/00365528209181092

KOLMANNSKOG F, SCHRUMPF E, BERGAN A, LARSEN S (1982)
DIAGNOSTIC-VALUE OF COMPUTED-TOMOGRAPHY IN PANCREATIC-CARCINOMA - A COMPARISON WITH OTHER RADIOLOGIC METHODS
ACTA RADIOL DIAGN, 23 (2), 131-141
DOI 10.1177/028418518202300209

KOLMANNSKOG F, SCHRUMPF E, VALNES K (1982)
COMPUTED-TOMOGRAPHY AND ANGIOGRAPHY IN PANCREATIC APUDOMAS AND CYSTADENOMAS
ACTA RADIOL DIAGN, 23 (4), 365-372
DOI 10.1177/028418518202300404

LINNESTAD P, SCHRUMPF E (1982)
EFFECT OF CHOLINERGIC AND ADRENERGIC-BLOCKADE ON HUMAN PANCREATIC-POLYPEPTIDE SECRETION IN HEALTHY-SUBJECTS
Scand. J. Gastroenterol., 17 (6), 801-809
DOI 10.3109/00365528209181097

SCHRUMPF E, FAUSA O, FORRE O, DOBLOUG JH, RITLAND S, THORSBY E (1982)
HLA ANTIGENS AND IMMUNOREGULATORY T-CELLS IN ULCERATIVE-COLITIS ASSOCIATED WITH HEPATOBILIARY DISEASE
Scand. J. Gastroenterol., 17 (2), 187-191
DOI 10.3109/00365528209182038

SCHRUMPF E, FAUSA O, KOLMANNSKOG F, ELGJO K, RITLAND S, GJONE E (1982)
SCLEROSING CHOLANGITIS IN ULCERATIVE-COLITIS - A FOLLOW-UP-STUDY
Scand. J. Gastroenterol., 17 (1), 33-39
DOI 10.3109/00365528209181041

SCHRUMPF E, GJONE E (1982)
PHYSICAL-ACTIVITY AND THE GASTROINTESTINAL-TRACT
Scand. J. Soc. Med. (29), 69-70

SCHRUMPF E, GJONE E (1982)
HEPATOBILIARY DISEASE IN ULCERATIVE-COLITIS
Scand. J. Gastroenterol., 17 (8), 961-964

SCHRUMPF E, LINNESTAD P (1982)
EFFECT OF CHOLINERGIC, ADRENERGIC, AND DOPAMINERGIC BLOCKADE ON GASTRIN-SECRETION IN HEALTHY-SUBJECTS
Scand. J. Gastroenterol., 17 (1), 29-31
DOI 10.3109/00365528209181040

SKREDE S, SOLBERG HE, RITLAND S, BLOMHOFF JP, SCHRUMPF E, ELGJO K, GJONE E (1982)
DIAGNOSTIC AND PROGNOSTIC VALUE OF LABORATORY TESTS ASSESSED IN A FOLLOW-UP-STUDY OF 200 PATIENTS WITH LIVER-DISEASE
Clin. Chem., 28 (5), 1177-1181

Publications 1981

KOLMANNSKOG F, SCHRUMPF E, BERGAN A, LARSEN S (1981)
DIAGNOSTIC-VALUE OF COMPUTER-TOMOGRAPHY IN CHRONIC-PANCREATITIS - A COMPARISON WITH CURRENT DIAGNOSTIC-TESTS
ACTA RADIOL DIAGN, 22 (6), 649-656
DOI 10.1177/028418518102200605

KOLMANNSKOG F, AAKHUS T, FAUSA O, SCHRUMPF E, RITLAND S, GJONE E, ELGJO K (1981)
CHOLANGIOGRAPHIC FINDINGS IN ULCERATIVE-COLITIS
ACTA RADIOL DIAGN, 22 (2), 151-157
DOI 10.1177/028418518102200208

SCHRUMPF E, BERGAN A, BLOMHOFF JP, HOEL PS, KOLMANNSKOG F (1981)
PARTIAL-HEPATECTOMY IN CAROLIS-DISEASE
Scand. J. Gastroenterol., 16 (5), 580-585

SCHRUMPF E, GIERCKSKY KE, NYGAARD K, FAUSA O (1981)
GASTRIN-SECRETION BEFORE AND AFTER GASTRIC BYPASS-SURGERY FOR MORBID-OBESITY
Scand. J. Gastroenterol., 16 (6), 721-725
DOI 10.3109/00365528109180995

SCHRUMPF E, LINNESTAD P, NYGAARD K, GIERCKSKY KE, FAUSA O (1981)
PANCREATIC-POLYPEPTIDE SECRETION BEFORE AND AFTER GASTRIC BYPASS-SURGERY FOR MORBID-OBESITY
Scand. J. Gastroenterol., 16 (8), 1009-1014
DOI 10.3109/00365528109181020

STOKKELAND M, SCHRUMPF E, HANSSEN AS, MYREN J, OSNES M, STADAAS J (1981)
INCIDENCE OF MALIGNANCIES OF THE BILLROTH-II OPERATED STOMACH - A PROSPECTIVE FOLLOW-UP
Scand. J. Gastroenterol., 16 67, 169-171

Publications 1980

BOHMAN T, MYREN J, FLATEN O, SCHRUMPF E (1980)
THE EFFECT OF TRIMIPRAMINE, CIMETIDINE, AND ATROPINE ON GASTRIC-SECRETION
Scand. J. Gastroenterol., 15 (2), 177-182
DOI 10.3109/00365528009181451

BOHMAN T, MYREN J, FLATEN O, SCHRUMPF E (1980)
THE EFFECT OF TRIMIPRAMINE, CIMETIDINE AND ATROPINE ON GASTRIC-SECRETION
Scand. J. Gastroenterol., 15 58, 53-56

MYREN J, PETERSEN H, BERSTAD A, SCHRUMPF E (1980)
PAPERS PRESENTED AT THE SYMPOSIUM ON PATHO-PHYSIOLOGY AND DRUG-THERAPY OF PEPTIC-ULCER - OSLO, 15-17 MARCH 1979 .1. - INTRODUCTION
Scand. J. Gastroenterol., 15 58, 5

SCHRUMPF E (1980)
THE EFFECT OF ANTACIDS ON GASTRIN-RELEASE
Scand. J. Gastroenterol., 15 58, 25-28

SCHRUMPF E, ELGJO K, FAUSA O, GJONE E, KOLMANNSKOG F, RITLAND S (1980)
SCLEROSING CHOLANGITIS IN ULCERATIVE-COLITIS
Scand. J. Gastroenterol., 15 (6), 689-697
DOI 10.3109/00365528009181516

Symposium on Pathophysiology and Drug Therapy of Peptic Ulcer, Myren J, Schrumpf E, Bergan T (1980)
Symposium on Pathophysiology and Drug Therapy of Peptic Ulcer
In Scandinavian journal of gastroenterology, Supplement, Taylor & Francis, Basingstoke, 58, 118 s.
BIBSYS 021231567

VATN MH, SCHRUMPF E, HANSSEN KF, MYREN J (1980)
A SMALL DOSE OF SOMATOSTATIN INHIBITS THE SECRETIN STIMULATED SECRETION OF BICARBONATE, AMYLASE, AND CHYMOTRYPSIN IN MAN
J. Endocrinol. Invest., 3 (3), 279-282
DOI 10.1007/BF03348276

Publications 1979

MYREN J, SCHRUMPF E, BOHMAN T, SKAUG OE, LARSEN S (1979)
SERUM CONCENTRATION OF TRIMIPRAMINE (SURMONTIL) AND GASTRIC-SECRETION OF ACID AND PEPSIN FOLLOWING PERORAL ADMINISTRATION OF THE DRUG IN HEALTHY HUMANS
Scand. J. Gastroenterol., 14 (2), 237-240
DOI 10.3109/00365527909179876

Publications 1978

BOHMAN T, SCHRUMPF E, MYREN J, FOSS OP (1978)
EFFECT OF TRIMIPRAMINE (SURMONTIL) ON STIMULATED GASTRIC-SECRETION AND SERUM GASTRIN CONCENTRATION IN HEALTHY STUDENTS
Scand. J. Gastroenterol., 13 48, 7-49

OSNES M, PETERSEN H, SCHRUMPF E (1978)
COMPARISON OF JUICE OBTAINED DURING DUODENAL ASPIRATION AND CANNULATION OF MAIN PANCREATIC DUCT AFTER STIMULATION WITH EXOGENOUS SECRETIN IN MAN
Scand. J. Gastroenterol., 13 (4), 453-458
DOI 10.3109/00365527809181921

SCHRUMPF E, VATN MH, HANSSEN KF, MYREN J (1978)
SMALL DOSE OF SOMATOSTATIN INHIBITS PENTAGASTRIN STIMULATED GASTRIC-SECRETION OF ACID, PEPSIN AND INTRINSIC-FACTOR IN MAN
Clin. Endocrinol., 8 (5), 391-395
DOI 10.1111/j.1365-2265.1978.tb02173.x

STADAAS JO, SCHRUMPF E, HANSSEN KF (1978)
SOMATOSTATIN INHIBITS GASTRIC MOTILITY IN RESPONSE TO DISTENTION
Scand. J. Gastroenterol., 13 (2), 145-148
DOI 10.3109/00365527809181740

Publications 1977

BOHMANN T, SCHRUMPF E, MYREN J (1977)
EFFECT OF TRIMIPRAMINE (SURMONTIL) ON GASTRIC-SECRETION AND SERUM GASTRIN RELEASE IN HEALTHY YOUNG STUDENTS
Scand. J. Gastroenterol., 12 43, 7-17

GRABNER P, SEMB LS, SCHRUMPF E, MYREN J (1977)
PLASMA GASTRIN AND GASTRIC SECRETORY RESPONSE TO DUODENAL PERFUSION WITH LIVER EXTRACT IN HEALTHY HUMAN SUBJECTS
Scand. J. Gastroenterol., 12 (7), 865-868
DOI 10.3109/00365527709181731

NORMANN T, NORMANN E, SCHRUMPF E, GAUTVIK KM (1977)
SECRETION OF CALCITONIN AND GASTRIN IN RATS WITH TRANSPLANTED MEDULLARY-THYROID CARCINOMA
ACTA PATH MICRO IM A, 85 (1), 63-72

SCHRUMPF E, STADAAS J, MYREN J, SERCKHANSSEN A, AUNE S, OSNES M (1977)
MUCOSAL CHANGES IN GASTRIC STUMP 20-25 YEARS AFTER PARTIAL GASTRECTOMY
Lancet, 2 (8036), 467-469

VATN MH, SCHRUMPF E, HANSSEN KF, MYREN J (1977)
EFFECT OF SOMATOSTATIN ON PENTAGASTRIN-STIMULATED GASTRIC-SECRETION AND ON PLASMA GASTRIN IN MAN
Scand. J. Gastroenterol., 12 (7), 833-839
DOI 10.3109/00365527709181727

Publications 1976

GRABNER P, SEMB LS, SCHRUMPF E, MYREN J (1976)
INTESTINAL PHASE OF GASTRIC-SECRETION - RESPONSE TO LIVER EXTRACT INFUSION INTO PROXIMAL JEJUNUM OF HEALTHY HUMAN SUBJECTS
Scand. J. Gastroenterol., 11 (4), 415-419

SCHRUMPF E, VATN MH, HANSSEN KF, SEMB LS, MYREN J (1976)
SOMATOSTATIN INHIBITS INSULIN-STIMULATED GASTRIN RELEASE AND GASTRIC-SECRETION OF ACID, PEPSIN, AND INTRINSIC-FACTOR (IF) IN DUODENAL-ULCER PATIENTS
Scand. J. Gastroenterol., 11 (5), 517-520

SCHRUMPF E, VATN MH, HANSSEN KF, SEMB LS, MYREN J (1976)
EFFECT OF SOMATOSTATIN ON GASTRIN RELEASE AND GASTRIC-SECRETION
Scand. J. Gastroenterol., 11 42, 41-42

SOLHAUG JH, SCHRUMPF E (1976)
EFFECT OF SMALL BOWEL BYPASS ON SERUM GASTRIN LEVELS AND GASTRIC-ACID SECRETION IN MAN
Scand. J. Gastroenterol., 11 (3), 329-332

Publications 1975

PETERSEN H, SCHRUMPF E, MYREN J (1975)
FASTING SERUM GASTRIN AND BASAL GASTRIC-ACID SECRETION
Scand. J. Gastroenterol., 10 (7), 721-724

VATN MH, SCHRUMPF E, MYREN J (1975)
EFFECT OF CARBACHOL AND PENTAGASTRIN ON GASTRIC-SECRETION OF ACID, PEPSIN, AND INTRINSIC FACTOR(IF) IN MAN
Scand. J. Gastroenterol., 10 (1), 55-58

VATN MH, SEMB LS, SCHRUMPF E (1975)
EFFECT OF ATROPINE AND VAGOTOMY ON SECRETION OF GASTRIC INTRINSIC FACTOR(IF) IN MAN
Scand. J. Gastroenterol., 10 (1), 59-64

Publications 1974

Schrumpf E (1974)
Studies on the regulation of the plasma gastrin concentration
Forfatteren, Oslo, 1b.(fl.pag.)
BIBSYS 010725377

SCHRUMPF E, MYREN J (1974)
EFFECT OF ATROPINE ON PLASMA CONCENTRATION OF GASTRIN IN FASTING SUBJECTS
Scand. J. Gastroenterol., 9 (2), 123-125

SCHRUMPF E, ROLAND M, LIAVAG I (1974)
SERUM GASTRIN AND GASTRIC-ACID SECRETION BEFORE AND AFTER PROXIMAL GASTRIC VAGOTOMY
Scand. J. Gastroenterol., 9 (2), 115-118

SCHRUMPF E, STADAAS J (1974)
EFFECT OF GASTRIC DISTENTION ON MOTILITY AND PLASMA GASTRIN CONCENTRATION BEFORE AND AFTER SECRETIN ADMINISTRATION
Scand. J. Gastroenterol., 9 (2), 119-122

SCHRUMPF E, VATN MH, SEMB LS (1974)
EFFECT OF ATROPINE ON INSULIN-STIMULATED GASTRIN RELEASE AND GASTRIC-SECRETION OF ACID, PEPSIN, AND INTRINSIC-FACTOR (IF)
Scand. J. Gastroenterol., 9 (7), 665-669

STADAAS J, SCHRUMPF E (1974)
INTRAGASTRIC PRESSURE-VOLUME RELATIONSHIP AND GASTRIN RELEASE AFTER DISTENTION OF SEPARATE PARTS OF STOMACH
Scand. J. Gastroenterol., 9 (8), 781-785

STADAAS J, SCHRUMPF E, HAFFNER JFW (1974)
EFFECT OF GASTRIC DISTENTION ON GASTRIC MOTILITY AND SERUM GASTRIN IN ACUTELY VAGOTOMIZED PIGS
Scand. J. Gastroenterol., 9 (2), 127-131

VATN MH, BERSTAD A, SCHRUMPF E (1974)
EFFECT OF CALCIUM AND PENTAGASTRIN ON GASTRIC-SECRETION OF ACID, PEPSIN, AND INTRINSIC-FACTOR (IF) IN MAN
Scand. J. Gastroenterol., 9 (7), 697-701

Publications 1973

SCHRUMPF E, MYREN J (1973)
EFFECT OF SECRETIN ON PLASMA CONCENTRATION OF GASTRIN IN FASTING PATIENTS WITH CARCINOMA OF STOMACH
Scand. J. Gastroenterol., 8 (6), 479-482

SCHRUMPF E, PETERSEN H, BERSTAD A, MYREN J, ROSENLUND B (1973)
EFFECT OF SECRETIN ON PLASMA GASTRIN IN ZOLLINGER-ELLISON SYNDROME
Scand. J. Gastroenterol., 8 (2), 145-150

SCHRUMPF E, SEMB LS (1973)
METABOLIC CLEARANCE RATE AND HALF-LIFE OF SYNTHETIC HUMAN GASTRIN IN DOGS
Scand. J. Gastroenterol., 8 (3), 203-207

SCHRUMPF E, SEMB LS, VOLD H (1973)
METABOLIC-CLEARANCE AND DISAPPEARANCE RATES OF SYNTHETIC HUMAN GASTRIN IN MAN
Scand. J. Gastroenterol., 8 (8), 731-734

Publications 1972

SCHRUMPF E, SAND T (1972)
RADIOIMMUNOASSAY OF GASTRIN WITH ACTIVATED CHARCOAL
Scand. J. Gastroenterol., 7 (8), 683-687
DOI 10.3109/00365527209180977